Anti-fibrotic therapy remains an unmet medical need in human chronic liver diseases. A research team led by Professor Norifumi Kawada, Osaka City University (OCU), reported the anti-fibrotic function ...
Researchers have discovered in mice an additional use of globins as an intravenous drug that can delay liver fibrosis progression. Anti-fibrotic therapy remains an unmet medical need in human chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results